Skip to main content
. 2022 Apr 1;22(6):791–801. doi: 10.1016/S1473-3099(22)00140-2

Figure 3.

Figure 3

Effectiveness of BNT162b2, ChAdOx1 nCoV-19, CoronaVac, and Ad26.COV2.S vaccines against symptomatic COVID-19 among individuals with previous SARS-CoV-2 infection